Perspective Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-5,239 | $1,909 |
Gross Profit | 462 | |||
EBITDA | -9,807 | |||
EBIT | -10,066 | |||
Net Income | -11,704 | -12,284 | -24,675 | -10,356 |
Net Change In Cash | 0 | 0 | -5,239 | 1,909 |
Free Cash Flow | -9,917 | 4,776 | -9,097 | -10,337 |
Cash | 252,004 | 142,117 | 9,238 | 17,983 |
Basic Shares | 67,425 | 58,691 | 28,180 | 280,558 |
Annual Financials
| Values in thousands | 2023-12-31 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $0 | $7,104 | $7,104 | $10,795 |
Gross Profit | 1,634 | 1,634 | 4,616 | |
EBITDA | -14,838 | -14,838 | -7,143 | |
EBIT | -15,182 | -15,182 | -7,391 | |
Net Income | -46,508 | -14,670 | -14,670 | -7,153 |
Net Change In Cash | 0 | 7,104 | 7,104 | 10,795 |
Free Cash Flow | -37,985 | -12,474 | -12,474 | -7,976 |
Cash | 9,238 | 20,993 | 20,993 | 55,890 |
Basic Shares | 28,180 | 142,103 | 142,103 | 141,987 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.18 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.09 |
2023-09-30 | -$0.04 |
